These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1987692)

  • 1. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
    Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
    Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
    Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
    Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.
    Haczku A; Alexander A; Brown P; Assoufi B; Li B; Kay AB; Corrigan C
    J Allergy Clin Immunol; 1994 Feb; 93(2):510-9. PubMed ID: 8120277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation.
    Vathsala A; Chou TC; Kahan BD
    Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive antagonism of low doses of FK506 and cyclosporine.
    Vathsala A; Goto S; Yoshimura N; Stepkowski S; Chou TC; Kahan BD
    Transplantation; 1991 Jul; 52(1):121-8. PubMed ID: 1713361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
    Luo H; Chen H; Daloze P; Chang J; Wu J
    Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
    [No Abstract]   [Full Text] [Related]  

  • 12. Responsiveness of preactivated B cells to IL-2 and IL-6. Effect of cyclosporine and rapamycin.
    Hornung N; Raskova J; Raska K; Degiannis D
    Transplantation; 1993 Oct; 56(4):985-90. PubMed ID: 7692641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use.
    Taylor-Fishwick DA; Kahan M; Hiestand P; Ritter MA; Foxwell BM
    Transplantation; 1993 Aug; 56(2):368-74. PubMed ID: 7689258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.
    Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL
    Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rapamycin on the expression of the IL-2 receptor (CD25).
    Woerly G; Brooks N; Ryffel B
    Clin Exp Immunol; 1996 Feb; 103(2):322-7. PubMed ID: 8565319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus.
    Khanna AK
    Transplantation; 2000 Aug; 70(4):690-4. PubMed ID: 10972232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 20. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine.
    Kimball PM; Kerman RH; Kahan BD
    Transplantation; 1991 Feb; 51(2):486-90. PubMed ID: 1825247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.